0 Rotavirus vaccination has reduced infant deaths in Malawi by a third
The first population-level evidence has proved the rotavirus vaccination saves lives in low-income settings.
Browsing: Clinical > Vaccines
0 Ebola vaccination initiated in North Kivu
Vaccination has begun to try and contain the second outbreak of Ebola seen in the Democratic Republic of Congo this year.
0 Can the human microbiome influence rotavirus vaccine response?
New study finds that the oral rotavirus vaccine response could be influenced by changes in the human microbiota.
0 UK committee recommends HPV vaccinations for adolescent boys
The Joint Committee on Vaccination and Immunisation has stated that a gender-neutral vaccine program would be cost effective in the UK and would protect boys against HPV infection and associated diseases.
0 Shigellosis – an update on the vaccine pipeline
Globally, shigella is reported to be the third largest cause of diarrheal mortality in the under-fives. We take a look at some of the vaccines that have made it to clinical development and some of the challenges still facing this diarrheal disease.
0 The APPROACH clinical trial produces positive results with a mosaic HIV-1 vaccine
Experimental HIV-1 vaccine regimen is safe and elicits a robust immune response according to results of a Phase I/IIa clinical trial.
0 Cholera in the Middle East and Africa – an interview with Martin Mengel
In this interview we take a look at cholera outbreak situations and the strategies required to tackle them as we talk to Martin Mengel following his presentation at ECCMID.
0 Vaccine success: study reports fall in HPV infections in women in England
A recent study has demonstrated a significant decrease in cases of human papilloma virus infection in England since the introduction of a bivalent vaccine in 2008.
0 Scientists set their sights on a new syphilis vaccine
Through a process of elimination, researchers have identified membrane surface proteins on T. pallaidum, which can be targeted by immune antibodies.
0 ASM Microbe: GeoVax present single-dose vaccines for Ebola, Lassa and Zika
At ASM Microbe GeoVax have spoken on the development of single-dose vaccines for emerging diseases using their MVA ‘Plug and Play’ platform technology.
